←
Wout Devlies79 posts
Wout Devlies avatar

Wout Devlies

@WoutDevlies

Prostate Cancer Aficionado. Research @KU_Leuven @DanaFarber and @UCLcancer, EAU guideline associate @uroweb, Urology Resident @UZLeuven

◷ Joined August 2015▧ 4 Photos and videos
Wout Devlies avatar
Wout Devlies@WoutDevlies·21 Nov 2024

Out now: joint analysis of single cell and spatial transcriptomic data from 120 patients. Proud of this team effort!

Our investigation into the prostate tumor microenvironment is now out in Nature Comms: nature.com/articles/s41467-0… We combined publicly available scRNA-seq data with in-house spatial transcriptomics samples to jointly anayze data from 120 patients. Here’s what we found 🧵 1/6

Post attachment
Bram De Laere avatar
⟳ Wout Devlies retweeted
Bram De Laere@BramDL·20 Aug 2024

Privileged seeing the @ProBioTrial published in @NatureMedicine My sincerest gratitude for all the dedicated doctors, nurses, lab personnel, trial managers, and most importantly, the patients who made this possible🙏 Thank you @komop_tgkanker for making ProBio possible in🇧🇪

🔥📢 The first results from the @ProBioTrial have been published in @NatureMedicine 🚀🌟 ARPIs outperform taxanes in metastatic #ProstateCancer: an outcome-adaptive randomized platform trial 🌟 nature.com/articles/s41591-0… [1/10]

Wout Devlies avatar
Wout Devlies@WoutDevlies·5 Jan 2024

Proud of our work from the Boston Lab on RT after neoadjuvant treatments in high-risk localized PCa: adjuvant RT rarely used and outcomes of both adjuvant and salvage poor. Patient selection will be key!

Outcomes of adjuvant and salvage RT in patients who have received neoadjuvant ARPI prior to RT for high-risk prostate cancer: our pooled analysis of trial patients published in #Prostatejournal - onlinelibrary.wiley.com/doi/…

Alexander Giesen avatar
⟳ Wout Devlies retweeted
Alexander Giesen@TheGiesen·22 Oct 2023

"Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients" @joniau @LoicBaekelandt @WoutDevlies @devos_gaetan @EveraertsW frontiersin.org/journals/onc…

Karel David avatar
⟳ Wout Devlies retweeted
Karel David@KarelDavid_·22 Nov 2023

Happy to see our work highlighted during this #Movember month! Don't forget the impact of #androgendeprivation on #bone in #prostatecancer patients! bit.ly/3G3LKkd Great collaboration with our urology department @devos_gaetan @WoutDevlies @joniau 👇👇👇

Post attachment

2nd highlight from November issue @KarelDavid_ & coll Report that androgen deprivation therapy results in bone loss as early as after 12 weeks in patients with non-metastasised prostate cancer Read bit.ly/3G3LKkd

Post attachmentPost attachment
Wout Devlies avatar
Wout Devlies@WoutDevlies·30 Aug 2023

Discover our work on the value of cystoscopy in bladder cancer detection, laying the basis for European and Canadian guidelines. Big team effort!

Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria .@Uroweb @MariaJRibal @ahmostafid @WoutDevlies @JoepJdeJong @maxbruins @EmmaJSmith9 @Cathyyuhongyuan @Phil_Violette @McMasterU Bas, Nancy, Tahilita, Fabian sciencedirect.com/science/ar…

Alumkal Lab avatar
⟳ Wout Devlies retweeted
Alumkal Lab@AlumkalJoshi·15 Sep 2022

Excited to share our new work on clinical enzalutamide resistance and lineage plasticity (LP) in prostate cancer through the @SU2C_PCF_WCDT out now in @NatureComms! nature.com/articles/s41467-0… @UMRogelCancer, @UMichCancBio, @umichrna, @PCF_Science, @DRSNmoonshot

Wout Devlies avatar
Wout Devlies@WoutDevlies·6 Jun 2022

Congrats Diogo to a very interesting set of neoadjuvant treated PCa, nicely complementary to our ARNEO study. Excited to see your future work. @MolendoKUL @joniau @devos_gaetan

Happy to share the results of our randomized phase II of intense ADT prior to prostatectomy for high-risk prostate cancer, including PSMA/PET correlation with path outcomes! @DrRanaMcKay @Silke_Gillessen @SoaresAndrey @RafaelFCoelho2 @montypal @g_develasco @DRathkopf

Post attachmentPost attachment